Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma
Wen-Peng Pang(Guangxi Medical University), Hongsheng Lin(Guangxi University), Xiaohang Lu(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Fuli Long(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Yunyong Wang(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Yuan Yu(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Mingfen Li, Minpeng Li(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine)
Cited by 6
Related Papers
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
|World Journal of Surgical Oncology|2022|115
The lncRNA MALAT1/miR-30/Spastin Axis Regulates Hippocampal Neurite Outgrowth
|Frontiers in Cellular Neuroscience|2020|31
Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases
|Medical Science Monitor|2018|23
LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia
|Scientific Reports|2022|12
Effect of Immune 2 with highly active antiretroviral treatment on immune function of HIV/AIDS patients with poor immune reconstitution
|China Journal of Chinese Materia Medica|2013|6